Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
36.02
-0.61 (-1.67%)
Oct 16, 2026, 3:00 PM CST
| Market Cap | 11.47B -26.3% |
| Revenue (ttm) | 2.89B +1.5% |
| Net Income | 978.57M -1.7% |
| EPS | 3.06 -1.1% |
| Shares Out | 318.32M |
| PE Ratio | 11.79 |
| Forward PE | n/a |
| Dividend | 1.76 (4.88%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 3,269,490 |
| Open | 36.84 |
| Previous Close | 36.63 |
| Day's Range | 35.67 - 37.12 |
| 52-Week Range | 34.80 - 49.85 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |